Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01216059 · ClinicalTrials.gov registry record · NA
Text Messaging and Atopic Dermatitis
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01216059 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 26 participants.
The verdict
NCT01216059, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Atopic dermatitis is a common problem faced by patients of all ages and backgrounds. Treatment regimens and specific therapies may be time consuming and multiple studies have documented a parallel decrease in compliance as time after an office visit increases. The adolescent population is an extremely challenging sub-group of patients in terms of complying with a treatment regimen. Not only are they striving for independence and thus lacking supervision of a regimen by a parent, but their complex thinking skills are immature, leading to forgetful behavior. By introducing a reminder system for these vulnerable patients that is easily incorporated into their daily lives, the investigators propose that patients will have better compliance at applying their medication and thus improving their atopic dermatitis. Text-messaging via cell phones has become very popular among teenagers and adults and provides a non-obtrusive method of sending a treatment reminder.
Interventions
- PROCEDURE Text message to cell phone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01216059
The ClinicalTrials.gov registry entry for NCT01216059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text message to cell phone is the first listed.
NCT01216059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01216059 about?
NCT01216059 is a clinical study titled "Text Messaging and Atopic Dermatitis". Atopic dermatitis is a common problem faced by patients of all ages and backgrounds. Treatment regimens and specific therapies may be time consuming and multiple studies have documented a parallel decrease in compliance as time after an office visit increases. The adolescent population is an extreme...
What is the current status of trial NCT01216059?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2010-10. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01216059?
The interventions under investigation include: Text message to cell phone (PROCEDURE).
Who is sponsoring clinical trial NCT01216059?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.